Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for their weight management indications for people with ...

Patients with plateaued weight loss or who reached their weight-related goals on a GLP-1 receptor agonist were able to ...

A federal judge has dismissed a lawsuit challenging the deportation of a doctor from Lebanon who was deported from Boston's ...

Among 200 eligible patients with a life expectancy of 6 months or less, access to palliative blood transfusions was of greatest importance when considering enrollment in hospice care, reported Oreofe ...

For the inaugural MedPage Today Culture Awards, the MedPage Today social media team recognized some of the biggest cultural ...

Tennessee ob/gyn Sanjeev Kumar, MD, has been indicted again for allegedly performing medically unnecessary gynecologic ...

Olympus said its investigations of clinical conditions identified a risk of endobronchial combustion if laser therapy, argon ...

Seven medical professionals accused of negligence in the death of Argentinian soccer player Diego Maradona will stand trial a ...

A staffing agency that works with international specialty nurses is suing President Trump and his administration over an ...

A rapid multidisciplinary approach is needed to reduce serum free light chain levels and restore kidney function ...

Physician groups were generally dissatisfied with the final 2026 Medicare Physician Fee Schedule rule released late last week by the Centers for Medicare & Medicaid Services (CMS).

The FDA approved linaclotide (Linzess) capsules to treat irritable bowel syndrome with constipation (IBS-C) in children age 7 ...